Enriching CRISPR-Cas9 targeted cells by co-targeting the HPRT gene

Shuren Liao1, Margaret Tammaro1, Hong Yan2

  • 1Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Insights

CRISPR-Cas9 gene editing efficiency is improved by co-targeting the hypoxanthine phosphoribosyltransferase (HPRT) gene. This method enriches successfully edited cells and helps identify ineffective guide RNAs or essential target genes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • CRISPR-Cas9 gene editing relies on guide RNAs to direct Cas9 cleavage.
  • Guide RNA efficiency varies, making it hard to troubleshoot failed experiments.
  • Identifying reasons for CRISPR-Cas9 failure, such as ineffective guide RNAs or essential target genes, is challenging.

Purpose of the Study:

  • To develop a method for enriching cells successfully targeted by CRISPR-Cas9.
  • To provide a way to distinguish between ineffective guide RNAs and essential target genes.
  • To improve the efficiency and scalability of CRISPR-Cas9 gene editing experiments.

Main Methods:

  • Developed a transient transfection method co-targeting the hypoxanthine phosphoribosyltransferase (HPRT) gene alongside the gene of interest.
  • Utilized two guide RNAs: one targeting HPRT and another targeting the gene of interest.
  • Selected HPRT-targeted cells by resistance to 6-thioguanine (6-TG) for analysis of gene of interest alterations.

Main Results:

  • Successfully enriched gene-targeted cells in both HCT116 and U2OS cell lines.
  • Demonstrated enrichment of alterations in genes like AAVS1, Exo1, and Trex1 in 6-TG resistant cells.
  • Established a scalable method applicable to multiple guide RNAs and genes.

Conclusions:

  • Co-targeting HPRT provides a robust strategy to enrich CRISPR-Cas9 gene editing events.
  • This method simplifies troubleshooting by differentiating between essential target genes and ineffective guide RNAs.
  • Offers a simple, efficient, and scalable approach to enhance gene targeting success.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.0K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
59.6K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.7K